PROFILE |
 |
Could Recordati cure whatever ails you in record time? Founded in 1926, the company makes prescription and nonprescription pharmaceuticals (about 70% of sales) and pharmaceutical ingredients (30%). Its prescription drug business includes antibiotics, antivirals, and treatments for cardiovascular, central nervous system, dermatological, respiratory, and other disorders and ailments. Over-the-counter products include treatments for allergies and colds, travel sickness, and fungal infections. Through its Vectorpharma subsidiary, the firm develops improved drug-delivery systems. Other subsidiaries are located in France, Spain, Switzerland, and the US. Recordati's products are sold in some 60 countries.
COMPETITION |
 |
Aventis (AVE)
Johnson & Johnson (JNJ)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
1999 Sales (mil.): 272.90
1-Yr. Sales Growth: 8.2%
Employees: 1,500
Revenue per employee: $181,933.33
KEY PEOPLE |
 |
Giovanni Recordati
CEO
Fritz Squindo
CFO
CONTACT INFO |
 |
Via Matteo Civitali, 1
20148 Milan, Italy
Phone: 39-02-48787-1
Fax: 39-02-4007-3747
Online: Web Site
|